More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.54B
EPS
-0.04
P/E ratio
--
Price to sales
2.96
Dividend yield
--
Beta
1.761567
Previous close
$11.81
Today's open
$11.97
Day's range
$11.52 - $12.04
52 week range
$4.90 - $12.85
show more
CEO
Mike Nassif
Employees
2974
Headquarters
Lansing, MI
Exchange
Nasdaq Global Select
Shares outstanding
218106005
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
Neogen Surges 102.8% in a Year: What's Driving the Rally?
NEOG shares gain 102.8% in a year as R&D investments, Food Safety growth and improving Animal Safety conditions fuel momentum despite key risks.
Zacks Investment Research • Aug 31, 2026

PRGO or NEOG: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
Zacks Investment Research • Aug 26, 2026

Neogen (NEOG) is a Great Momentum Stock: Should You Buy?
Does Neogen (NEOG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Aug 24, 2026

Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock
Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks Investment Research • Aug 11, 2026

PRGO vs. NEOG: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Aug 10, 2026

Neogen Q4 Earnings Call Highlights
Neogen NASDAQ: NEOG reported fiscal fourth-quarter revenue of $225.3 million, with core revenue growth of 4.3%, its highest growth rate of fiscal 2026. The company said momentum improved across both its food safety and animal safety businesses as it entered fiscal 2027, while management outlined increased spending on research and development, commercial capabilities and technology.
MarketBeat • Jul 30, 2026

Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript
Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript
Seeking Alpha • Jul 30, 2026

Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal fourth quarter and full fiscal year 2026 and provided financial guidance for its fiscal year first quarter and full fiscal year 2027. “We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way we approach customers and our core markets. Fiscal ye.
Business Wire • Jul 30, 2026

Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Jul 30, 2026

Neogen (NEOG) Beats Q4 Earnings and Revenue Estimates
Neogen (NEOG) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.
Zacks Investment Research • Jul 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Neogen Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.